No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CNMD ConMed
- 70.010
- -1.300-1.82%
Close Apr 24 16:00 ET
- 67.000
- -3.010-4.30%
Post 16:43 ET
2.16BMarket Cap34.32P/E (TTM)
71.770High69.780Low1.19MVolume71.770Open71.310Pre Close83.73MTurnover3.90%Turnover Ratio34.32P/E (Static)30.79MShares137.64752wk High2.58P/B2.14BFloat Cap69.78052wk Low0.80Dividend TTM30.52MShs Float156.120Historical High1.14%Div YieldTTM2.79%Amplitude6.783Historical Low70.258Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Conmed Corp : JP Morgan Cuts Target Price to $75 From $115
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
Conmed Corp (CNMD) Q1 2024 Earnings: Surpasses Revenue Estimates, Aligns With EPS Projections
Express News | Corrected-Conmed Outlook FY Revenue USD 1,330-1,355 Million
Conmed Names Patrick Beyer to New COO Role
By Ben Glickman Conmed on Wednesday named Patrick Beyer to the newly created role of chief operating officer. Beyer joined the Largo, Fla.-based medical technology company in 2014 and is president o
Conmed Corp. Q1 Income Climbs, but Misses Estimates
Comments
CONMED's ROE is deemed 'sub-optimal'. The business isn't thrilling as it uses high debt to boost sub-par returns. Theoretically, greater ROE could improve through leverage, but higher debt presents greater risk.
CONMED's stock appears overpriced when gauged against the industry average PE ratio. Despite its positive outlook being factored into its valuation, the elevated price could present a risk to potential sellers and isn't the optimum entry point for potential investors.
CONMED's move to profitability is typically seen as a good sign but investor sentiment may be changing due to recent share price drop. The company exhibits two cautionary signs for investors.
ColumnsToday's pre-market stock movers: CRM, WB, LI, NIO and more
Gainers:
• $Victoria's Secret(VSCO.US$ +10.4% (In reaction to earnings)
• $Salesforce(CRM.US$ +9.0% (In reaction to earnings)
• $Navigator(NVGS.US$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo(WB.US$ +4.7% (In reaction to earnings)
• $CAE Inc(CAE.US$ +4.7% (In reaction to earnings)
• $Laredo Petroleum(LPI.US$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics(AXSM.US$ +3.1% (Late-Breaking Presentations of P...
• $Victoria's Secret(VSCO.US$ +10.4% (In reaction to earnings)
• $Salesforce(CRM.US$ +9.0% (In reaction to earnings)
• $Navigator(NVGS.US$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo(WB.US$ +4.7% (In reaction to earnings)
• $CAE Inc(CAE.US$ +4.7% (In reaction to earnings)
• $Laredo Petroleum(LPI.US$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics(AXSM.US$ +3.1% (Late-Breaking Presentations of P...
21
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
wooperOP : FYI is just getting started will run all day